Champions Oncology, Inc. (CSBR)
4.99
+0.02
(+0.40%)
USD |
NASDAQ |
Oct 06, 16:00
4.99
0.00 (0.00%)
After-Hours: 19:39
Champions Oncology Cash from Operations (Quarterly) : -0.492M for July 31, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2026 | -0.492M |
| April 30, 2026 | -1.998M |
| January 31, 2026 | -1.339M |
| October 31, 2025 | -1.735M |
| July 31, 2025 | 0.60M |
| April 30, 2025 | 6.868M |
| January 31, 2025 | 0.49M |
| October 31, 2024 | -0.283M |
| July 31, 2024 | 0.311M |
| April 30, 2024 | -1.816M |
| January 31, 2024 | -0.919M |
| October 31, 2023 | 0.589M |
| July 31, 2023 | -3.991M |
| April 30, 2023 | -0.692M |
| January 31, 2023 | 1.573M |
| October 31, 2022 | 3.286M |
| July 31, 2022 | -0.195M |
| April 30, 2022 | 0.796M |
| January 31, 2022 | 4.257M |
| October 31, 2021 | 1.228M |
| July 31, 2021 | 0.216M |
| April 30, 2021 | -1.98M |
| January 31, 2021 | 0.135M |
| October 31, 2020 | 0.879M |
| July 31, 2020 | -0.715M |
| Date | Value |
|---|---|
| April 30, 2020 | 2.545M |
| January 31, 2020 | 0.279M |
| October 31, 2019 | 0.36M |
| July 31, 2019 | -0.279M |
| April 30, 2019 | 0.252M |
| January 31, 2019 | 1.21M |
| October 31, 2018 | 0.064M |
| July 31, 2018 | 0.336M |
| April 30, 2018 | 0.009M |
| January 31, 2018 | 0.445M |
| October 31, 2017 | 0.268M |
| July 31, 2017 | -1.948M |
| April 30, 2017 | 0.398M |
| January 31, 2017 | -0.683M |
| October 31, 2016 | -0.101M |
| July 31, 2016 | -2.454M |
| April 30, 2016 | -0.599M |
| January 31, 2016 | -0.726M |
| October 31, 2015 | -2.597M |
| July 31, 2015 | -2.543M |
| April 30, 2015 | -2.008M |
| January 31, 2015 | -2.376M |
| October 31, 2014 | -2.46M |
| July 31, 2014 | -2.788M |
| April 30, 2014 | 0.098M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Medpace Holdings, Inc. | 162.01M |
| Avantor, Inc. | 178.20M |
| Personalis, Inc. | -25.77M |
| Adaptive Biotechnologies Corp. | -6.40M |
| 10X Genomics, Inc. | 16.97M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.055M |
| Cash from Financing (Quarterly) | 0.033M |
| Free Cash Flow | -6.137M |
| Free Cash Flow Per Share (Quarterly) | -0.0394 |
| Free Cash Flow to Equity (Quarterly) | -6.919M |
| Free Cash Flow to Firm (Quarterly) | -0.547M |
| Free Cash Flow Yield | -8.76% |